Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients

doi:10.4254/wjh.v9.i9.469

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10352)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

439

WORD

258

HTML

3896

Figures (1-3)

221

Tables (1-3)

218

Sum=5032

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

468

Download

1375

Sum=1843

Publishing Process of This Article

Item

Count

Browse

1226

Download

2251

Sum=3477

Mar 28, 2017 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Hepatol. Mar 28, 2017; 9(9): 469-476
Published online Mar 28, 2017. doi: 10.4254/wjh.v9.i9.469

Full Size Figure Download Figure

Figure 1 Box-plot diagram that shows the annexin A2 level in the three groups. HCC: Hepatocellular carcinoma.

Citation: Shaker MK, Abdel Fattah HI, Sabbour GS, Montasser IF, Abdelhakam SM, El Hadidy E, Yousry R, El Dorry AK. Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients. World J Hepatol 2017; 9(9): 469-476
URL: https://www.wjgnet.com/1948-5182/full/v9/i9/469.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i9.469